Retatrutide 15mg

Retatrutide is a next-generation investigational peptide studied for its multi-receptor activity across GLP-1, GIP, and glucagon pathways — positioning it as one of the most advanced compounds in metabolic and energy-balance research.

This tri-agonist profile has generated significant scientific interest for its role in supporting glucose regulation, metabolic rate, lipid balance, and body-energy dynamics in research models.

Research areas include potential support for:

• Metabolic energy regulation
• Appetite & satiety signaling pathways
• Glucose balance & insulin signaling
• Lipid metabolism & fat-utilization studies
• Mitochondrial activity + energy output

Retatrutide has emerged as a leading molecule in studies focused on weight-related metabolic biology, endocrine response, and multi-receptor hormone modulation.*

🔬 Scientific Insight

Retatrutide is engineered to activate GLP-1, GIP, and glucagon receptors simultaneously — a multi-axis approach being explored for its potential to accelerate metabolic signaling, energy expenditure, and adaptive fat-use pathways.

This triple-mechanism makes it a compelling candidate for advanced metabolic and obesity-biology research, alongside GLP-1 mono-agonists and dual incretin compounds.